Insmed Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Great. Good afternoon, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here. Very pleased to have Will Lewis, the CEO of Insmed with us.
Quickly before we get started, I just need to read a disclosure statement. Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.
Questions & Answers
So Will, thanks for being here. I thought maybe we'd start off with TPIP, just because you've got some upcoming data there. And maybe the best place to start is just talk to people because I think they're probably a little less familiar, I know you've probably been educating people here, but less familiar with the kind of study you're running here and the endpoints. And so maybe just help people think
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
